综述专论

人促甲状腺激素作用机制及生物活性方法研究进展*

展开
  • 1.中国药科大学 生命科学与技术学院,南京 210009;
    2.中国食品药品检定研究院 药品监管科学全国重点实验室国家卫生健康委员会生物技术产品检定方法及其标准化重点实验室,北京 102629
第一作者 Tel:18261937785;E-mail:17861405031@163.com
**梁成罡 Tel:(010)53851638;E-mail:liangchenggang@nifdc.org.cn
李 晶 Tel:(010)53851465;E-mail:li_jing@nifdc.org.cn

收稿日期: 2024-04-07

  网络出版日期: 2024-08-05

基金资助

*药品监管科学全国重点实验室(2023SKLDRS0108)

Research progress on the mechanism of action and bioactivity methods of human thyroid-stimulating hormone*

Expand
  • 1. China Pharmaceutical University College of Life Science and Technology, Nanjing 210009, China;
    2. National Institutes for Food and Drug Control, State Key Laboratory of Drug Regulatory Science, NHC Key Laboratory of Research on Quality and Standardization of Biotech Products, Beijing 102629, China

Received date: 2024-04-07

  Online published: 2024-08-05

摘要

促甲状腺激素(thyroid-stimulating hormone,TSH)是由垂体前叶产生的糖蛋白激素。可调节甲状腺滤泡细胞中甲状腺激素的合成和分泌,具有重要生理学意义,作为药物具有重要应用价值,生物学活性检测是评价其质量的有效和必要手段,本文就促甲状腺激素的信号转导作用机理、促甲状腺激素的临床诊断与治疗、生物学活性测定方法进行论述。

本文引用格式

高婧, 梁成罡, 李晶 . 人促甲状腺激素作用机制及生物活性方法研究进展*[J]. 药物分析杂志, 2024 , 44(7) : 1105 -1112 . DOI: 10.16155/j.0254-1793.2024-0226

Abstract

Thyroid-stimulating hormone (TSH) is a glycoprotein hormone produced by the anterior pituitary. It can regulate the synthesis and secretion of thyroid hormone in thyroid follicular cells, which has important physiological significance. As a drug, it has important application value. Biological activity detection is an effective and necessary to evaluate its quality. This article discusses the signal transduction mechanism of thyroid stimulating hormone, the clinical diagnosis and treatment of thyroid stimulating hormone, and the determination method of biological activity.

参考文献

[1] GOURGIOTIS L, SKARULIS MC. Clinical uses of recombinant human thyrotropin[J]. Expert Opin Pharmacother, 2004, 5(12): 2503
[2] FREITAS J. Development and Validation of In Vitro Bioassays for Thyroid Hormone Receptor Mediated Endocrine Disruption[M]. USA: ResearchGate, 2012:9
[3] ZOELLER RT, TAN SW, TYL RW. General background on the hypothalamic-pituitary-thyroid (HPT) axis[J]. Crit Rev Toxicol, 2007, 37(1-2): 11
[4] HOLLENBERG AN. The role of the thyrotropin-releasing hormone (TRH) neuron as a metabolic sensor[J]. Thyroid, 2008, 18(2): 131
[5] EGHTEDARI B, CORREA R. Levothyroxine[J/OL].Treasure Island (FL):StatPearls [Internet], 2023[2024-04-07]https://www.ncbi.nlm.nih.gov/books/NBK539808/
[6] CHU YD, YEH CT. The molecular function and clinical role of thyroid stimulating hormone receptor in cancer cells[J]. Cells, 2020, 9(7): 1730
[7] KURSAWE R, PASCHKE R. Modulation of TSHR signaling by posttranslational modifications[J]. Trends Endocrinol Metab, 2007, 8(5): 199
[8] PEREIRA SS, LOBATO CB, MONTEIRO MP. Cell signaling within endocrine glands: thyroid, parathyroids and adrenal glands[J]. Tissue-Specific Cell Signaling, 2020, 3: 63
[9] BENVENGA S, NORDIO M, LAGANÀ AS, et al. The role of inositol in thyroid physiology and in subclinical hypothyroidism management [J]. Front Endocrinol(Lausanne), 2021, 12: 12662582
[10] MAENHAUT C, CHRISTOPHE D, VASSART G, et al. Ontogeny, anatomy, metabolism and physiology of the thyroid[J/OL]. South Dartmouth (MA):Endotext [Internet], 2015 [2024-04-07]. https://www.ncbi.nlm.nih.gov/books/NBK285554/
[11] CORVILAIN B, LAURENT E, LECOMTE M, et al. Role of the cyclic adenosine 3', 5'-monophosphate and the phosphatidylinositol-Ca2+ cascades in mediating the effects of thyrotropin and iodide on hormone synthesis and secretion in human thyroid slices[J]. J Clin Endocrinol Metab, 1994, 79(1): 152
[12] ROSE SR, CHUANG JS. TSH Function and Secretion[M]//Encyclopedia of Endocrine Diseases. 2nd Ed, 2017:408
[13] 张志杰, 肖萍, 明子桔, 等. 血清TSH和Tg联合检测对分化型甲状腺癌的诊断价值[J].婚育与健康, 2023, 29(11): 76
ZHANG ZJ, XIAO P, MING ZJ, et al. Value of serum TSH and Tg combined detection in the diagnosis of differentiated thyroid carcinoma[J]. Fertil Health, 2023, 29(11): 76
[14] 罗惠, 王健楠, 李影. 血清TSH和Hcy水平诊断甲减的价值[J]. 中国卫生标准管理, 2020, 11(13): 114
LUO H, WANG JN, LI Y. Value of serum TSH and Hcy levels in diagnosis of hypothyroidism[J]. China Health Stand Managem, 2020, 11(13): 114
[15] 徐晋豫. 甲状腺疾病患者促甲状腺激素与甲状腺自身抗体水平的检测及意义[J]. 慢性病学杂志, 2019, 20(1): 90
XU JY. Detection and significance of thyroid stimulating hormone and thyroid autoantibody levels in patients with thyroid disease[J]. Chron Pathematol J, 2019, 20(1): 90
[16] CAPPOLA AR, LADENSON PW. Hypothyroidism and atherosclerosis[J].J Clin Endocrinol Metab, 2003, 88(6): 2438
[17] ABDI H, KAZEMIAN E, GHARIBZADEH S, et al. Association between thyroid function and body mass index: a 10-year follow-up[J]. Ann Nutr Metab, 2017, 70(4): 338
[18] ASVOLD BO, BJØRO T, NILSEN TI, et al. Association between blood pressure and serum thyroid-stimulating hormone concentration within the reference range: a population-based study[J]. J Clin Endocrinol Metab, 2007, 92(3): 841
[19] CANARIS GJ, MANOWITZ NR, MAYOR G, et al. The colorado thyroid disease prevalence study[J]. Arch Intern Med, 2000, 160(4): 526
[20] AREM R, ESCALANTE DA, AREM N, et al. Effect of L-thyroxine therapy on lipoprotein fractions in overt and subclinical hypothyroidism, with special reference to lipoprotein(a)[J]. Metabolism, 1995, 44(12): 1559
[21] ABE E, MARIANS CR, YU W, et al. TSH is a negative regulator of skeletal remodeling[J]. Cell, 2003, 115(2): 151
[22] SENDAK RA, SAMPATH TK, MCPHERSON JM. Newly reported roles of thyroid-stimulating hormone and follicle-stimulating hormone in bone remodelling[J]. Int Orthop, 2007, 31(6): 753
[23] 董华, 许丽颖, 李明. 促甲状腺激素治疗甲状腺癌的疗效及对生化和内分泌指标的影响[J]. 实用癌症杂志, 2021, 36(8): 1285
DONG H, XU LY, LI M. Effect of thyroid stimulating hormone in the treatment of thyroid cancer and its influence on biochemical and endocrine indicators[J]. Pract J Cancer, 2021, 36(8): 1285
[24] FAUSER B, CHANG J, AZZIZ R, et al.Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS)[J]. Hum Reprod, 2004, 19(1):41
[25] HASHIM AH. Twenty years of ovulation induction with metformin for PCOS; what is the best available evidence?[J]. Reprod Biomed Online, 2016, 32(1): 44
[26] 刘文英, 季新梅, 游华蓉. 促甲状腺激素水平与多囊卵巢综合征患者性激素、血脂及胰岛素抵抗的关系[J]. 中国综合临床, 2018, 9(5): 455
LIU WY, JI XM, YOU HR. Relationship among thyroid stimulating hormone level and sex hormones, blood lipids and insulin resistance in patients with polycystic ovary syndrome[J]. Clin Med China, 2018, 9(5): 455
[27] 吴玥辰. 探讨促甲状腺激素治疗多囊卵巢综合征对患者糖脂代谢及生殖内分泌功能的影响[J]. 当代医学, 2021, 27(32): 133
WU YC. To explore the effect of thyroid-stimulating hormone treatment of polycystic ovary syndrome on glucose and lipid metabolism and reproductive endocrine function in patients[J]. Contemp Med, 2021, 27(32): 133
[28] MCKENZIE JM. The bioassay of thyrotropin in serum[J]. Endocrinology, 1958, 63(3):372
[29] BIDEY SP, RYDER K, GAINESDAS R, et al. A comparison of the bioactivity of human and bovine thyrotrophin preparations, as determined by intracellular cyclic AMP responses of cultured FRTL-5 cells and human thyroid cell monolayers[J]. Acta Endocrinol(Copenh), 1984, 106(4): 482
[30] THOTAKURA NR, LICALZI L, WEINTRAUB BD. The role of carbohydrate in thyrotropin action assessed by a novel approach using enzymatic deglycosylation[J]. J Biol Chem, 1990, 265(20): 11527
[31] ENDO Y, TETSUMOTO T, NAGASAKI H, et al. The distinct roles of alpha- and beta-subunits of human thyrotropin in the receptor-binding and postreceptor events[J]. Endocrinology, 1990, 127(1): 149
[32] VAN MT, ANNA G, JU YP, et al. Highly sensitive ELISA using membrane-based microwave-mediated electrochemical immunoassay for thyroid-stimulating hormone detection[J]. IEEE Sens J, 2019, 19(21): 9826
[33] LIU J, YU C, HAN L, et al. Upconversion luminescence-based aptasensor for the detection of thyroid-stimulating hormone in serum[J]. Microchim Acta, 2022, 189(5): 179
[34] HUSSAIN A, ZIMMERMAN CA, BOOSE JA, et al. Large scale synthesis of recombinant human thyrotropin using methotrexate amplification: chromatographic, immunological, and biological characterization[J]. J Clin Endocrinol Metab, 1996, 81(3): 1184
[35] PATTERSON SD, HUANG X, JORGENSEN HG, et al. Transcriptional regulation by the NFAT family in acute myeloid leukaemia[J]. Hemato, 2021, 2(3): 556
文章导航

/